GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GoodRx Holdings Inc (NAS:GDRX) » Definitions » Beneish M-Score

GoodRx Holdings (GoodRx Holdings) Beneish M-Score

: -2.62 (As of Today)
View and export this data going back to 2020. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.62 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for GoodRx Holdings's Beneish M-Score or its related term are showing as below:

GDRX' s Beneish M-Score Range Over the Past 10 Years
Min: -2.9   Med: -2.62   Max: -2.61
Current: -2.62

During the past 6 years, the highest Beneish M-Score of GoodRx Holdings was -2.61. The lowest was -2.90. And the median was -2.62.


GoodRx Holdings Beneish M-Score Historical Data

The historical data trend for GoodRx Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GoodRx Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Premium Member Only - - -2.61 -2.90 -2.62

GoodRx Holdings Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.90 -3.02 -2.89 -2.86 -2.62

Competitive Comparison

For the Health Information Services subindustry, GoodRx Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GoodRx Holdings Beneish M-Score Distribution

For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where GoodRx Holdings's Beneish M-Score falls into.



GoodRx Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of GoodRx Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.344+0.528 * 1.0047+0.404 * 1.0757+0.892 * 0.9788+0.115 * 0.7029
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9494+4.679 * -0.090101-0.327 * 1.057
=-2.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $160.0 Mil.
Revenue was 196.644 + 179.958 + 189.677 + 183.986 = $750.3 Mil.
Gross Profit was 181.474 + 161.237 + 173.338 + 167.291 = $683.3 Mil.
Total Current Assets was $872.8 Mil.
Total Assets was $1,588.8 Mil.
Property, Plant and Equipment(Net PPE) was $45.9 Mil.
Depreciation, Depletion and Amortization(DDA) was $107.7 Mil.
Selling, General, & Admin. Expense(SGA) was $466.8 Mil.
Total Current Liabilities was $122.6 Mil.
Long-Term Debt & Capital Lease Obligation was $696.1 Mil.
Net Income was -25.869 + -38.495 + 58.786 + -3.29 = $-8.9 Mil.
Non Operating Income was 0 + -2.2 + 0 + -1.808 = $-4.0 Mil.
Cash Flow from Operations was 15.868 + 60.27 + 29.866 + 32.288 = $138.3 Mil.
Total Receivables was $121.7 Mil.
Revenue was 184.109 + 187.318 + 191.798 + 203.329 = $766.6 Mil.
Gross Profit was 166.749 + 169.923 + 173.754 + 191.049 = $701.5 Mil.
Total Current Assets was $919.7 Mil.
Total Assets was $1,604.6 Mil.
Property, Plant and Equipment(Net PPE) was $55.7 Mil.
Depreciation, Depletion and Amortization(DDA) was $54.2 Mil.
Selling, General, & Admin. Expense(SGA) was $502.4 Mil.
Total Current Liabilities was $76.3 Mil.
Long-Term Debt & Capital Lease Obligation was $705.9 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(160.045 / 750.265) / (121.665 / 766.554)
=0.213318 / 0.158717
=1.344

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(701.475 / 766.554) / (683.34 / 750.265)
=0.915102 / 0.910798
=1.0047

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (872.79 + 45.861) / 1588.8) / (1 - (919.686 + 55.726) / 1604.631)
=0.421796 / 0.392127
=1.0757

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=750.265 / 766.554
=0.9788

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(54.177 / (54.177 + 55.726)) / (107.668 / (107.668 + 45.861))
=0.492953 / 0.701288
=0.7029

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(466.843 / 750.265) / (502.423 / 766.554)
=0.622237 / 0.655431
=0.9494

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((696.106 + 122.559) / 1588.8) / ((705.927 + 76.32) / 1604.631)
=0.515273 / 0.487493
=1.057

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-8.868 - -4.008 - 138.292) / 1588.8
=-0.090101

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

GoodRx Holdings has a M-score of -2.62 suggests that the company is unlikely to be a manipulator.


GoodRx Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of GoodRx Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


GoodRx Holdings (GoodRx Holdings) Business Description

Traded in Other Exchanges
N/A
Address
2701 Olympic Boulevard, Santa Monica, CA, USA, 90404
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Executives
Scott Wagner officer: Interim Chief Executive Office C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304
Raj Beri officer: Chief Operating Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Romin Nabiey officer: Chief Accounting Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Andrew Slutsky officer: President & Consumer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Idea Men, Llc 10 percent owner 2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404
Karsten Voermann officer: Chief Financial Officer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Trevor Bezdek director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Abdiel Qualified Master Fund Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Douglas Joseph Hirsch director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Babak Azad officer: See Remarks 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Bansi Nagji officer: President, Healthcare MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039
Agnes Rey-giraud director
Abdiel Capital Lp 10 percent owner C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Advisors, Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Management, Llc 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016